american diabetes association 'history of pancreatitis' glp-1 receptor agonist glucagon-like peptide-1 agonists with cardiovascular and kidney outcomes in type 2 diabetic kidney transplant recipients | Cardiovascular Diabetology Glucagon-Like Peptide-1 Receptor Agonists–Health Professional
Description
All in all, Liraglutide is a potent GLP-1 receptor agonist and has the potential for Type 2 diabetes research
Frontiers in endocrinology
Algorithm for patients presenting for elective surgery while taking glucagon-like peptide-1 receptor agonists (GLP-1 RAs)
Subcutaneous injection (Ozempic, Wegovy): Ozempic is known to reduce cardiovascular events, whereas, Wegovy injections have shown efficacy in controlling obese and overweight individuals
doi:10.1210/jcem.83.7.4877 127
